Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine.
Pharmacology, Biochemistry, and Behavior October 2018 Vivian B Neis, Luis B Bettio, Morgana Moretti et al.
Agmatine is a neuromodulator that has been proposed as a therapeutic strategy for the treatment of major depressive disorder (MDD). A previous study reported that agmatine caused a fast-acting effect in mice subjected to chronic mild stress without causing changes in the levels of synaptic proteins in the prefrontal cortex. We examined whether a single administration of agmatine is able to...
DOI: 10.1016/j.pbb.2018.08.005 (opens in new tab)
Full text (opens in new tab)
Agmatine
Antidepressant
Corticosterone
Synaptic proteins